GR930100426A - Παράγωγα βενζ(-e)ινδενίου. - Google Patents

Παράγωγα βενζ(-e)ινδενίου.

Info

Publication number
GR930100426A
GR930100426A GR930100426A GR930100426A GR930100426A GR 930100426 A GR930100426 A GR 930100426A GR 930100426 A GR930100426 A GR 930100426A GR 930100426 A GR930100426 A GR 930100426A GR 930100426 A GR930100426 A GR 930100426A
Authority
GR
Greece
Prior art keywords
derivatives
group
alkyl
benzene
nitrogen atom
Prior art date
Application number
GR930100426A
Other languages
English (en)
Inventor
Gabor Dr Blasko
Zoltan Dr Budai
Marton Dr Fekete
Istvan Gacsalyi
Gabor Gigler
Istvan Dr Gyertyan
Tibor Dr Mezei
Luiza Petocz
Klara Reiter
Ludmilla Rohacs
Gyula Dr Simig
Maria Szecsey
Katalin Dr Szemeredi
Eniko Szirt
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of GR930100426A publication Critical patent/GR930100426A/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/60—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups having oxygen atoms of carbamate groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

Η εφεύρεση αφορά νέα, φαρμακευτικώς δραστικά βενζ(ε)ινδενοπαράγωγα μία μέ?οδο δια την παρασκευή αυτών, φαρμακευτικές συν?έσεις που περιεχουν αυτά, περαιτέρω την χρησιμοποίηση των αναφερ?έντων παραγώγων βενζ(ε)ινδενίου εις την αγωγή ορισμένων ασ?ενειών και κατά την παρασκευή φαρμακευτικών συν?έσεων καταλλήλων δια την αγωγή των αναφερ?έντων ασ?ενειών.Τα νέα παράγωγα βενζ(ε)ινδενίου συμφωνως προς την εφεύρεση αντιστοιχούν εις τον γενικό τύπο. Χ Η Μ Ι Κ Ο Σ Τ Υ Π Ο Σ εις τον οποίο το Α παριστά μια ομάδα του τύπου Alk-NR1R2, όπου το alk παριστά μια C2-7 αλκυλενομάδα ενδεχομένως φέρουσα έναν υδροξυ υποκαταστάτη, τα R1 και R2 είναι ανεξαρτήτως υδρογόνου, C1-7-αλκυλ, C2-7-αλκυνυλ, C2-7-αλκυνυλ ή C3-7-κυκλοαλκυλ ή τα R1 και R2 μαζί με το άτομο αζώτου εις το οποίο είναι συνδεδεμένα σχηματίζουν εναν 4 έως 7 μελή δακτυλιο, ενδεχομένως περιέχοντα ένα άτομο οξυγόνου ή ένα περαιτέρω άτομο αζώτου, το οποίο τελευταίο μπορεί να φέρει ένα φαινυλ, βενζυλ, πυριδυλ, πυριμιδινυλ ή C 1-3 αλκυλυπόλοκαταστάτη, οι οποίοι υποκατάστάτες δύνανται πάλιν να φέρουν μια υδροξυ ή με?οξυομάδα ή ένα άτομο αλογόνου ήR1 και R2 μαζί με το άτομο αζώτου εις το οποίο αυτά είναι συνδεδεμένα σχηματίζουν μια φ?αλιμιδοομάδα ή το Α παριστά πυριμιδινο, 2,3-εποξυπροπυλ ή μια ομάδα του τύπου -C(O)NHR,όπου το R3 παριστά C1-7 αλκυλ, C2-7 αλκενυλ ή C3-8 κυκλοαλκυλ και το R σημαίνει υδρογόνο ή C1-7 αλκυλ,στερεοισομερή και οπτικώς δραστικά ισομερή και τα πι?ανά μίγματα αυτών, περαιτέρω άλατα δια προσ?ήκης οξέος και τεταρτοταγή παραγωγα αμμωνίου των ενώσεων αυτών.ω
GR930100426A 1992-10-30 1993-10-29 Παράγωγα βενζ(-e)ινδενίου. GR930100426A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9203406A HU212262B (en) 1992-10-30 1992-10-30 Process to prepare benz /e/ indene derivs. and the pharmaceutical compns. contg. them

Publications (1)

Publication Number Publication Date
GR930100426A true GR930100426A (el) 1994-06-30

Family

ID=10982489

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100426A GR930100426A (el) 1992-10-30 1993-10-29 Παράγωγα βενζ(-e)ινδενίου.

Country Status (17)

Country Link
US (1) US5439940A (el)
EP (1) EP0595364B1 (el)
JP (1) JPH0770033A (el)
CN (1) CN1089939A (el)
AT (1) AT403580B (el)
CA (1) CA2102042A1 (el)
CZ (1) CZ230893A3 (el)
DE (1) DE69303798T2 (el)
DK (1) DK0595364T3 (el)
ES (1) ES2099658B1 (el)
FI (1) FI934823A (el)
FR (1) FR2697520B1 (el)
GR (1) GR930100426A (el)
HU (2) HU212262B (el)
IT (1) IT1272762B (el)
YU (1) YU68693A (el)
ZA (1) ZA938087B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5312743B2 (ja) * 2006-02-01 2013-10-09 富士フイルム株式会社 オキシム化合物及びそれを含む感光性組成物
KR20090104877A (ko) * 2007-01-23 2009-10-06 후지필름 가부시키가이샤 옥심 화합물, 감광성 조성물, 컬러 필터, 그 제조방법 및 액정표시소자
JP2008249857A (ja) * 2007-03-29 2008-10-16 Fujifilm Corp 感光性樹脂組成物、カラーフィルタ及びその製造方法、並びに液晶表示素子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6503019A (el) * 1965-03-10 1966-09-12
SE371193B (el) * 1972-03-24 1974-11-11 Kabi Ab
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
HU178518B (en) * 1978-12-19 1982-05-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing cyclododekanone oxime ethers
AU532700B2 (en) * 1979-04-02 1983-10-13 Sumitomo Chemical Company, Limited Diphenylalkanoether
HU212415B (en) * 1989-08-25 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
EP0595364A1 (en) 1994-05-04
FR2697520B1 (fr) 1995-03-24
ATA218893A (de) 1997-08-15
DE69303798T2 (de) 1996-11-28
CZ230893A3 (en) 1994-06-15
FI934823A (fi) 1994-05-01
AT403580B (de) 1998-03-25
ES2099658A1 (es) 1997-05-16
HU212262B (en) 1996-04-29
ES2099658B1 (es) 1998-02-01
ITMI932303A1 (it) 1995-04-29
ITMI932303A0 (it) 1993-10-29
FI934823A0 (fi) 1993-10-29
EP0595364B1 (en) 1996-07-24
US5439940A (en) 1995-08-08
HU211494A9 (en) 1995-11-28
HU9203406D0 (en) 1993-01-28
DK0595364T3 (da) 1996-08-26
IT1272762B (it) 1997-06-26
DE69303798D1 (de) 1996-08-29
JPH0770033A (ja) 1995-03-14
CN1089939A (zh) 1994-07-27
HUT68238A (en) 1995-06-28
FR2697520A1 (fr) 1994-05-06
ZA938087B (en) 1994-06-07
CA2102042A1 (en) 1994-05-01
YU68693A (sh) 1997-07-31

Similar Documents

Publication Publication Date Title
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
HU910874D0 (en) 1,4,7,10-tetraaza-cyclododecane-butyl-thiol derivatives, process for producing these compounds and pharmaceutical preapratives containing them
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO945034L (no) Derivater i vitamin D-serien modifisert ved 20-stilling, en fremg. for frems. av slike derivater, mellomprodukter anvendt ved fremg., farmasöytiske preparater inneholdende derivatene og deres anvendelse ved frems. av legemidler
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
PT653427E (pt) Derivados de galantamina processo para a sua preparacao e sua utilizacao como medicamentos
GB9211172D0 (en) Compounds
ES2061077T3 (es) Metodo para producir un producto intermedio para la preparacion de promedicamentos.
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
FI906408A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
GR930100426A (el) Παράγωγα βενζ(-e)ινδενίου.
NO885714D0 (no) Fremgangsmaate for fremstilling av propoksybenzenderivater.
GR1000997B (el) Μεθοδος για την παρασκευη παραγωγων 8-χλωροκινολονης.
BR1101133A (pt) Derivado de sinergistina, (quinuclidinil-3(s) tiometil-5 bem como seus sais farmaceuticamente aceitáveis, processo de preparação do derivado de sinergistina e composição farmacêutica
PT76903B (en) Process for preparing novel derivatives of guanine and of pharmaceutical compositions containing the same
AU576888B2 (en) Benzodisultams
GR880100526A (el) Φαρμακευτικα παρασκευασματα δια εξωτερικην χρησιν.
ATE59647T1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ES8308547A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI842533A0 (fi) Hexahydropyrrolo/2,1-a/isokinolin- derivat.
AU6101390A (en) Substituted purines for use in the treatment of viruses
NO303494B1 (no) Tetrahydronaftalenderivater, fremgangsmÕte for deres fremstilling og farmas°ytisk preparat inneholdende et slikt derivat, samt mellomprodukter
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas